Phenominer Database Results (16 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait male 276 days-280 days 5 49.0 mmHg 2.0 4.47 tail cuff plethysmography 0.0 0 n=5-7, change between age 9months and 10 months 106742 3039
SBH/Ygl systolic blood pressure controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait male 70 days 5 195.0 mmHg 3.0 6.71 tail cuff plethysmography 0.0 0 106753 3039
SBH/Ygl both kidneys wet weight to body weight ratio deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x. kidney mass male 16 days 8 3.0 g/kg 0.08 0.23 post excision weight measurement 0.0 0 n=8-15 106650 3035
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (for 30 days) and deoxycorticosterone acetate (25 mg) (for 30 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait female 52 days-56 days 5 56.0 mmHg 2.0 4.47 tail cuff plethysmography 0.0 0 n=5-7, change between age 1month and 2 months 106731 3039
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait female 192 days-196 days 5 46.0 mmHg 4.0 8.94 tail cuff plethysmography 0.0 0 n=5-7, change between age 6 months and 7 months 106739 3039
SBH/Ygl systolic blood pressure controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days) Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. arterial blood pressure trait male 0 days 13 serial mean 197.0 mmHg 1.0 3.61 tail cuff photoplethysmography 172800 0 photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) 12236 236
SBH/Ygl systolic blood pressure controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait female 70 days 9 196.0 mmHg 2.0 6.0 tail cuff plethysmography 0.0 0 106755 3039
SBH/Ygl body weight deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x. body mass male 16 days 8 340.0 g 8.9 25.17 body weighing method 0.0 0 n=8-15 106644 3035
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (for 30 days) and deoxycorticosterone acetate (25 mg) (for 30 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait male 52 days-56 days 5 52.0 mmHg 3.0 6.71 tail cuff plethysmography 0.0 0 n=5-7, change between age 1month and 2 months 106730 3039
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait male 360 days-364 days 5 52.0 mmHg 3.0 6.71 tail cuff plethysmography 0.0 0 n=5-7, change between age 12months and 13 months 106746 3039
SBH/Ygl systolic blood pressure controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days) Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. arterial blood pressure trait female 0 days 14 serial mean 194.0 mmHg 1.0 3.74 tail cuff photoplethysmography 172800 0 photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) 12237 236
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait male 108 days-112 days 5 58.0 mmHg 4.0 8.94 tail cuff plethysmography 0.0 0 n=5-7, change between age 3months and 4 months 106734 3039
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait female 360 days-364 days 5 53.0 mmHg 1.0 2.24 tail cuff plethysmography 0.0 0 n=5-7, change between age 12months and 13 months 106747 3039
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait male 192 days-196 days 5 54.0 mmHg 2.0 4.47 tail cuff plethysmography 0.0 0 n=5-7, change between age 6 months and 7 months 106738 3039
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait female 276 days-280 days 5 51.0 mmHg 2.0 4.47 tail cuff plethysmography 0.0 0 n=5-7, change between age 9months and 10 months 106743 3039
SBH/Ygl absolute change in systolic blood pressure controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006. arterial blood pressure trait female 108 days-112 days 5 55.0 mmHg 7.0 15.65 tail cuff plethysmography 0.0 0 n=5-7, change between age 3months and 4 months 106735 3039